Texas § 266.001 DEFINITIONS.

Texas Statutes

§ 266.001 — DEFINITIONS.

Texas § 266.001

Code FAFamily Code

This text of Texas § 266.001 (DEFINITIONS.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Family Code Code Ann. § 266.001 (2026).

Text

Sec. 266.001. DEFINITIONS. In this chapter:

(1)"Advanced practice nurse" has the meaning assigned by Section 157.051 , Occupations Code. (1-a) "Commission" means the Health and Human Services Commission. (1-b) "Commissioner" means the commissioner of the Department of Family and Protective Services.

(2)"Department" means the Department of Family and Protective Services. (2-a) "Drug research program" means any clinical trial, clinical investigation, drug study, or active medical or clinical research that has been approved by an institutional review board in accordance with the standards provided in the Code of Federal Regulations, 45 C.F.R. Sections 46.404 through 46.407, regarding:

(A)an investigational new drug; or

(B)the efficacy of an approved drug.

(3)"Executive commissioner" mean

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 266.001. DEFINITIONS. In this chapter:
(1) "Advanced practice nurse" has the meaning assigned by Section 157.051 , Occupations Code.
(1-a) "Commission" means the Health and Human Services Commission.
(1-b) "Commissioner" means the commissioner of the Department of Family and Protective Services.
(2) "Department" means the Department of Family and Protective Services.
(2-a) "Drug research program" means any clinical trial, clinical investigation, drug study, or active medical or clinical research that has been approved by an institutional review board in accordance with the standards provided in the Code of Federal Regulations, 45 C.F.R. Sections 46.404 through 46.407, regarding:
(A) an investigational new drug; or
(B) the efficacy of an approved drug.
(3) "Executive commissioner" means the executive commissioner of the Health and Human Services Commission.
(4) Repealed by Acts 2015, 84th Leg., R.S., Ch. 944 , Sec. 86(40), eff. September 1, 2015.
(4-a) "Investigational new drug" has the meaning assigned by 21 C.F.R. Section 312.3(b).
(5) "Medical care" means all health care and related services provided under the medical assistance program under Chapter 32 , Human Resources Code, and described by Section 32.003 (4), Human Resources Code.
(6) "Physician assistant" has the meaning assigned by Section 157.051 , Occupations Code.
(7) "Psychotropic medication" means a medication that is prescribed for the treatment of symptoms of psychosis or another mental, emotional, or behavioral disorder and that is used to exercise an effect on the central nervous system to influence and modify behavior, cognition, or affective state. The term includes the following categories when used as described by this subdivision:
(A) psychomotor stimulants;
(B) antidepressants;
(C) antipsychotics or neuroleptics;
(D) agents for control of mania or depression;
(E) antianxiety agents; and
(F) sedatives, hypnotics, or other sleep-promoting medications.

Legislative History

Added by Acts 2005, 79th Leg., Ch. 268 (S.B. 6 ), Sec. 1.65(a), eff. September 1, 2005. Amended by: Acts 2007, 80th Leg., R.S., Ch. 506 (S.B. 450 ), Sec. 1, eff. September 1, 2007. Acts 2013, 83rd Leg., R.S., Ch. 204 (H.B. 915 ), Sec. 7, eff. September 1, 2013. Acts 2015, 84th Leg., R.S., Ch. 944 (S.B. 206 ), Sec. 86(40), eff. September 1, 2015. Acts 2017, 85th Leg., R.S., Ch. 316 (H.B. 5 ), Sec. 17, eff. September 1, 2017.